Age differences of patients treated with wearable cardioverter defibrillator: Data from a multicentre registry

Author:

El‐Battrawy Ibrahim123ORCID,Tenbrink David1,Kovacs Boldizsar4,Dreher Tobias C.5,Blockhaus Christian67,Klein Norbert89,Shin Dong‐In67,Hijazi Mido10,Rosenkaimer Stephanie5,Beiert Thomas5,Abumayyaleh Mohammad5,Saguner Ardan Muammer4,Kowitz Jacqueline5,Erath Julia W.11,Duru Firat4,Mügge Andreas123,Aweimer Assem1,Akin Ibrahim512

Affiliation:

1. Department of Cardiology and Angiology, Bergmannsheil University Hospitals Ruhr University of Bochum Bochum Germany

2. Department of Molecular and Experimental Cardiology, Institut für Forschung und Lehre (IFL) Ruhr University Bochum Bochum Germany

3. Institute of Physiology Ruhr University Bochum Bochum Germany

4. Department of Cardiology, University Heart Center University Hospital Zurich Zürich Switzerland

5. Faculty Medicine of Heidelberg, University Mannheim University Heidelberg Mannheim Germany

6. Department of Cardiology, Heart Centre Niederrhein Helios Clinic Krefeld Krefeld Germany

7. Faculty of Health, School of Medicine University Witten/Herdecke Witten Germany

8. Department of Cardiology, Angiology and Internal Intensive‐Care Medicine Klinikum St. Georg gGmbH Leipzig Leipzig Germany

9. Department of Internal Medicine II University Hospital Bonn, University of Bonn Bonn Germany

10. Department of Neurosurgery University Hospital Carl Gustav Carus, Technische Universität Dresden Dresden Germany

11. Department of Cardiology Frankfurt University Hospital, Goethe University Frankfurt am Main Germany

12. DZHK (German Center for Cardiovascular Research), Partner Site Heidelberg‐Mannheim Mannheim Germany

Abstract

AbstractBackgroundWearable cardioverter defibrillators (WCD) are used as a ‘bridging’ technology in patients, who are temporarily at high risk for sudden cardiac death (SCD). Several factors should be taken into consideration, for example patient selection, compliance and optimal drug treatment, when WCD is prescribed. We aimed to present real‐world data from seven centres from Germany and Switzerland according to age differences regarding the outcome, prognosis, WCD data and compliance.Materials and MethodsBetween 04/2012 and 03/2021, 1105 patients were included in this registry. Outcome data according to age differences (old ≥45 years compared to young <45 years) were analysed. At young age, WCDs were more often prescribed due to congenital heart disease and myocarditis. On the other hand, ischaemic cardiomyopathy (ICM) was more present in older patients. Wear days of WCD were similar between both groups (p = .115). In addition, during the WCD use, documented arrhythmic life‐threatening events were comparable [sustained ventricular tachycardia: 5.8% vs. 7.7%, ventricular fibrillation (VF) .5% vs. .6%] and consequently the rate of appropriate shocks was similar between both groups. Left ventricular ejection fraction improvement was documented over follow‐up with a better improvement in younger patients as compared to older patients (77% vs. 63%, p = .002). In addition, at baseline, the rate of atrial fibrillation was significantly higher in the older age group (23% vs. 8%; p = .001). The rate of permanent cardiac implantable electronic device implantation (CiED) was lower in the younger group (25% vs. 36%, p = .05). The compliance rate defined as wearing WCD at least 20 h per day was significantly lower in young patients compared to old patients (68.9% vs. 80.9%, p < .001). During the follow‐up, no significant difference regarding all‐cause mortality or arrhythmic death was documented in both groups. A low compliance rate of wearing WCD is predicted by young patients and patients suffering from non‐ischaemic cardiomyopathies.ConclusionAlthough the compliance rate in different age groups is high, the average wear hours tended to be lower in young patients compared to older patients. The clinical events were similar in younger patients compared to older patients.

Publisher

Wiley

Subject

Clinical Biochemistry,Biochemistry,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3